Hereditary fibrinogen A α-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation
Open Access
- 15 April 2010
- journal article
- Published by American Society of Hematology in Blood
- Vol. 115 (15), 2998-3007
- https://doi.org/10.1182/blood-2009-06-223792
Abstract
Variants of fibrinogen A α-chain (AFib) cause the most common type of hereditary renal amyloidosis in Europe and, possibly, the United States as well. Variant fibrinogen is produced in the liver, and solitary renal allografts fail within 1 to 7 years with recurrent amyloidosis. We assessed 22 AFib patients for combined liver and kidney transplantation (LKT) and report the clinical features and outcome. Twenty-one had E526V and 1, the R554L variant. Coronary atherosclerosis was identified in 68% and systemic atheromatosis in 55%. Vascular atheroma excised at endarterectomy and endomyocardial biopsies contained purely variant fibrinogen amyloid. Half had autonomic neuropathy. Six of 9 patients who underwent LKT are alive (67%), with good allograft function and no amyloidosis at median 67 months (range, 33-155 months) of follow-up. Serial technetium-99m–labeled dimercaptosuccinic acid (99mTc-DMSA) renal scintigraphy in 2 cases of preemptive LKT demonstrated preserved native kidney residual function at 5 years. Four explanted livers were used successfully for domino transplantation. Fibrinogen amyloidosis is a systemic amyloid disease with visceral, vascular, cardiac, and neurologic involvement. LKT is curative; however, cardiovascular amyloidosis may preclude this option. Our data encourage evaluation of preemptive solitary liver transplantation early in the course of amyloid nephropathy to prevent hemodialysis and kidney transplantation.Keywords
This publication has 32 references indexed in Scilit:
- Diagnosis, Pathogenesis, Treatment, and Prognosis of Hereditary Fibrinogen Aα-Chain AmyloidosisJournal of the American Society of Nephrology, 2009
- Three German fibrinogen Aα-chain amyloidosis patients with the p.Glu526Val mutationVirchows Archiv A Pathological Anatomy and Histopathology, 2008
- Human plasma fibrinogen is synthesized in the liverBlood, 2006
- Hereditary amyloidosis in early childhood associated with a novel insertion-deletion (indel) in the fibrinogen Aα chain geneKidney International, 2005
- Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and AmyloidosisAmerican Journal of Hematology, 2005
- Kidney Disease as a Risk Factor for Development of Cardiovascular DiseaseHypertension, 2003
- Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen α‐chain variant in an English familyQJM: An International Journal of Medicine, 2000
- Fibrinogen Aa Chain Leu 554: an African-American kindred with late onset renal amyloidosisAmyloid, 1998
- The molecular basis of renal amyloidosis in Irish-American and Polish-Canadian kindredsQJM: An International Journal of Medicine, 1996
- Variant apolipoprotein AI as a major constituent of a human hereditary amyloidBiochemical and Biophysical Research Communications, 1988